Treatment with 100 μM of SLC-0111 for 72 h affects the viability of the high-malignant acid cancer subpopulation particularly addicted to CAIX activity, i.e., the cells growing under specific conditions of acidosis within the tumor mass of the breast, melanoma and colorectal tumors. The gene discussed is CA9; the disease is melanoma.